Guided Tour
 View Your Account
 Shop for Stocks
 Research Stocks
 Educate Yourself
 Family Investing
 Retirement Focus
 Our Strategy
 About Us
 Helpdesk
 Home
Google Custom Search
 
Symbol Lookup
Profile
HBIO - Harvard Bioscience Inc (NASDAQ GM) 12:00 AM ET, 03/26/2015 
 Last: 5.49 Change: +0.06 %Change: +1.10% Volume: 767,700  
Detailed QuoteSEC FilingsProfileNewsChart
Harvard Bioscience Inc (NASDAQ GM:HBIO)
84 October Hill Road
Holliston, MA 01746
Phone: (508) 893-8999
Fax: (508) 429-5732
http://www.harvardbioscience.com
Harvard Bioscience Inc is a Delaware corporation, which began its business in 1901. The Companydeveloper, manufacturer and marketer of scientific instruments, systems and lab consumables used to advance life science for basic research, drug discovery, clinical and environmental testing. It has sales and manufacturing operationsin the United States, the United Kingdom, Germany, Sweden, Spain, France, Canada, and China.The Company sells its products to researchers in over 100 countries through itssales organization, websites, catalogs, and through distributors including Thermo Fisher Scientific Inc., VWR, GE Healthcare, and other specialized distributors.The Company core product range is organized into five product families: Fluidics, Lab Equipment and Supplies, Molecular Analysis, Cell Physiology, and Animal Physiology. It primarily sells these products under brand names, including Harvard Apparatus, KD Scientific, Denville Scientific, AHN, Hoefer, Biochrom, BTX, Warner Instruments, MCS, HEKA, Hugo Sachs Elektronik, Panlab, Coulbourn Instruments, TBSI, and CMA Microdialysis.The Fluidics product family includes Company's traditional syringe pump and peristaltic pump product lines. The products are used in many life science and industrial applications that require accurately controlled fluid dispensing, including infusion, perfusion, cellular microinjection, microfluidics, mass spectrometry calibration, electrospinning and microdialysis. The primary brands are Harvard Apparatus, Harvard Pumps, and KD Scientific.The Lab Equipment and Supplies product family includes products for molecular biology labs with a liquid handling focus. It consists of pipettes and pipette tips, gloves, gel electrophoresis equipment and reagents, autoradiography films, thermal cycler accessories and reagents, sample preparation columns, tissue culture products, and general lab equipment and consumables. Its brands include Denville Scientific, AHN, and others. The Molecular Analysis product family includes spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation instruments. The Company sells spectrophotometers under the names Libra, WPA and BioDrop. The Cell Physiology product family consists of electrophysiology products. The Animal Physiology product family includes instruments and accessories for tissue, organ and animal based lab research, including surgical products, infusion systems, microdialysis instruments, behavior research systems, isolated organ and tissue bath systems, bioreactors for regenerative medicine research, and in vivo electrophysiology recording and stimulation systems. Itsproduct offerings are marketed through Harvard Apparatus, CMA Microdialysis, Panlab, Coulbourn, Hugo-Sachs, InBreath Bioreactor, MCS and TBSI brands and entities. The Company competes with several companies that provides instruments for life science research including, Lonza Group Ltd., Becton Dickinson, Eppendorf AG, Kent Scientific Corporation, Razel Scientific Instruments,Inc., Ugo Basile, Danaher Corporation, Bio-Rad Laboratories,Inc., PerkinElmer,Inc. and Thermo Fisher Scientific, Inc.The Company is not subject to direct governmental regulation other than the laws and regulations generally applicable to businesses in the domestic and foreign jurisdictions in which it operates.
 Sector:Biotechnology 
 Number of Employees:417 
 Share Information
 Shares
 Outstanding:
33.2M 
 Market Cap:182.1M 
 Cash Flow (per sh):0.19 
 Book Value:2.88 
 Fundamentals
 EPS:0.07 
 P/E Ratio:78.43 
 Dividend:0.00 
 Yield:0.00 
 Management Effectiveness
 Return on Equity (1 year):2.50 
 Return on Assets (1 year):1.70 
 Return on Investment (1 year):2.10 
 Performance
 52wk High
 (12/31/2014):
5.93 
 52wk Low
 (6/25/2014):
3.68 
 Key Financials
Revenue Total Net Income Earnings/Share EBITDA Long Term Debt 
 2014$108.7M $2.4M $0.07 $10.8M $16.5M 
 2013$105.2M $-1.8M $-0.06 $9.8M $19.8M 



Quotes delayed at least 15 minutes. Market data provided by Interactive Data.
Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.
Fundamental data provided by Morningstar, Inc.


BUYandHOLD does not offer or provide any investment advice or opinion regarding the nature, potential, value, suitability or profitability of any particular security, portfolio of securities, transaction or investment strategy. Any investment decisions you make will be based solely on your evaluation of your financial circumstances, investment objectives, risk tolerance, and liquidity needs. The security and information listed above and is being provided for informational purposes only and should not be regarded as an offer to sell or as a solicitation of an offer to buy and past performance is no guarantee of future results.

The BUYandHOLD website contains links to third-party websites on the Internet. BUYandHOLD provides these links to these websites only as a convenience to users of the website. Links on the BUYandHOLD website are not endorsements by BUYandHOLD or Freedom Investments, implied or express, of the linked sites or any products, services or links in such sites; and no information in such sites has been endorsed or approved by BUYandHOLD. Linked sites are not under the control of BUYandHOLD or Freedom Investments, and we are not responsible for the contents of any linked site or any link contained in a linked site. No information contained in the BUYandHOLD website or accessed through any linked site, or any link contained in a linked site, constitutes a recommendation by BUYandHOLD or Freedom Investments to buy, sell or hold any security, financial product or instrument. Information accessed through linked sites is not, nor should be construed as, an offer or a solicitation of an offer, to buy or sell securities by BUYandHOLD or Freedom Investments. BUYandHOLD does not offer or provide any investment advice or opinion regarding the nature, potential, value, suitability or profitability of any particular security, portfolio of securities, transaction or investment strategy, and any investment decisions you make will be based solely on your evaluation of your financial circumstances, investment objectives, risk tolerance, and liquidity needs.

Copyright © 1999 – 2014 Freedom Investments. All Rights Reserved.
Freedom Investments, Inc. Member FINRA/SIPC
Privacy & Security